AtriCure Inc. (NSDQ:ATRC), a maker of medical devices used in atrial fibrillation today announced encouraging mid-term results in an unofficial trial for persistent Afib (atrial fibrillation) in Europe which may bode well for the company going forward.
Atrial fibrillation, often referred to as "afib," is an irregular heartbeat, a rapid heartbeat, or a quivering of the upper chambers of the heart, called the atria. Atrial fibrillation is due to a malfunction in the heart's electrical system, and is the most common heart irregularity, or cardiac arrhythmia. Afib is an irregular heart beat that affects up to 2% of the world's population.
As we age, the incidence of atrial fibrillation increases. As Baby Boomers continue to age, we can...
|FREE||SA PRO MEMBERS|
|IDEA GENERATOR||X||Exclusive access to 10 PRO ideas every day|
|INVESTING IDEAS LIBRARY||X||Exclusive access to PRO library of more than 15,000 ideas|
|SECTOR EXPERT NETWORK||X||Exclusive access to all sector experts for direct consultation|
|PERFORMANCE TRACKING||X||Track performance of all PRO stock ideas|
|PROFESSIONAL TOOLS||X||Professional Idea Filters to zero-in based on industry, market cap and more|